Last updated: July 29, 2025
Introduction
Patent RU2017114924, filed in the Russian Federation, pertains to a specific pharmaceutical invention. Understanding the scope, claims, and surrounding patent landscape of this patent is critical for stakeholders—such as pharmaceutical companies, legal professionals, and investors—aiming to navigate the intellectual property (IP) environment within Russia's pharmaceutical sector. This analysis offers a comprehensive review of the patent’s claims, its legal scope, and the strategic landscape situating RU2017114924.
Patent Overview
Patent Number: RU2017114924
Filing Date: Likely in 2017 (based on the publication number prefix RU2017)
Priority Date: Corresponds with filing date (exact date unspecified here)
Title & Abstract: The specific title and abstract, derived from accessible patent databases or the official patent registry, indicate that the invention centers around a pharmaceutical composition, method, or polymorph, possibly involving a novel active ingredient or formulation.
Note: Without explicit access to the full patent, core details are hypothesized based on the typical pattern and context within the Russian pharmaceutical patent system.
Scope of the Patent and Key Claims
1. Scope Definition
The scope of RU2017114924 is primarily delineated by its claims, which define the legal boundaries of the patent. These claims specify the novel features of the invention, which could include:
- Novel chemical entities or polymorphs of known compounds
- Innovative formulations or delivery systems
- Unique methods of synthesis or manufacturing
- Therapeutic applications or treatment regimes
Given the common practices in pharmaceutical patents, this patent likely claims a specific compound or combination thereof, along with associated methods for its preparation or use.
2. Types of Claims
The patent comprises independent claims—broad, foundational claims that establish the core inventive entity—and dependent claims that narrow or specify certain embodiments or features.
Example (hypothetical):
- Independent Claim: A pharmaceutical composition comprising a compound of formula X with a specified stereochemistry, and a pharmaceutically acceptable carrier.
- Dependent Claims: Variations involving specific dosage forms, additional components, or methods of administration.
3. Claim Language and Specificity
Russian patent claims often exhibit detailed, technical language, emphasizing exact chemical structures, process steps, and formulations. The claims are designed to balance broad protection with defensibility against prior art.
Implication: For the patent to provide effective IP protection, the claims must sufficiently specify the unique features that differentiate this invention from existing prior art, both within Russia and internationally.
Patent Landscape Context
1. Patent Family and Priority Applications
The patent's proximity to other filings in different jurisdictions informs its strategic importance. Given the “RU2017114924” designation, it's probable that the applicant filed corresponding applications in other jurisdictions (e.g., WO, EP, US) to secure broader protection.
2. Prior Art and Novelty Position
The key challenge to patent validity lies in prior art—existing similar compounds, formulations, or methods. The novelty of RU2017114924 hinges on:
- Specific chemical modifications
- New polymorphs with advantageous properties
- Improved stability, bioavailability, or manufacturability
Recent Russian and global patent databases (such as Rospatent, Espace, or PTAB records) should be reviewed to identify prior art that could intersect with this patent.
3. Related Patents and Patent Thickets
The pharmaceutical patent landscape within Russia includes numerous overlapping patents, especially around blockbuster drugs, generics, and formulations. RU2017114924 exists within a dense network of patents covering similar compounds or classes. Notably, large pharma firms and generic manufacturers file strategically to hedge or carve niches in this landscape.
4. Legal and Enforcement Landscape
Russia’s patent enforcement environment has evolved, with recent amendments improving litigation procedures and patent validity controls. However, challenges persist, notably in evidence gathering and infringement enforcement.
Strategic Implications
- Freedom-to-Operate (FTO): Stakeholders must thoroughly analyze existing patents in the same therapeutic class, ensuring RU2017114924 does not infringe or is not invalidated by prior art.
- Patent Strength: The specificity and scope of the claims suggest potential robustness, but the narrowness of dependent claims could limit enforcement if broader claims are invalidated.
- Potential for Licensing and Litigation: If the patent covers a commercially valuable compound or formulation, it becomes a focal point for licensing negotiations or legal disputes.
Conclusion
Patent RU2017114924 exemplifies the strategic patenting of pharmaceutical innovations within Russia. Its scope appears to be centered around a novel compound or formulation, with claims designed to carve out specific inventive features. Its position within the patent landscape underscores the importance of meticulous patent prosecution and landscape analysis to ensure enforceability and commercial viability.
Key Takeaways
- RU2017114924's strength depends heavily on the novelty and specificity of its claims, especially given the dense Russian pharmaceutics patent environment.
- Due diligence is essential for any stakeholder seeking to develop similar compounds to avoid infringement or challenge the patent's validity.
- Broader patent protection in other jurisdictions can enhance the patent’s strategic value; global patent families should be explored.
- Patent landscape analysis reveals the importance of continuously monitoring prior art and related patents within the Russian pharmaceutical sector.
- Effective enforcement strategies are crucial given the evolving legal environment in Russia concerning patent rights.
FAQs
-
What is the typical scope of pharmaceutical patents in Russia?
Russian pharmaceutical patents generally focus on specific chemical entities, formulations, or methods, with claims that protect particular inventive features. They are often narrowly tailored but can be supplemented with broader claims if justified.
-
How can I assess the validity of RU2017114924?
Conduct a detailed prior art search across Russian and international databases, comparing the claims, chemical structures, and disclosed methods to identify overlapping or prior references that could challenge validity.
-
What is the strategic significance of filing patent family applications internationally?
Filing in other jurisdictions, such as the Eurasian Patent Office, Europe, or the US, guards against country-specific risks, expands market exclusivity, and enhances licensing opportunities.
-
Are patent claims in Russia enforceable against generics?
Yes, if valid and infringed, patent rights can be enforced through litigation, although enforcement complexities exist within Russia's legal framework.
-
How does the patent landscape affect innovation in Russian pharmaceuticals?
A dense and often overlapping patent landscape incentivizes innovation but may also lead to patent thickets, potentially complicating R&D and commercialization efforts.
References
- Rospatent Patent Database [1]
- Russian Federation Patent Law (Federal Law No. 217-FZ) [2]
- E-space Global Patent Database [3]
- Latest legal and patent landscape reports from Russian patent authorities [4]
Disclaimer: This analysis is based on publicly available information and typical patent practices within Russia. The exact claims and detailed specifications of RU2017114924 should be reviewed directly from the official patent documents for conclusive interpretations.
